Literature DB >> 21072619

Relaxin-3/INSL7 regulates the stress-response system in the rat hypothalamus.

Yoshihisa Watanabe1, Yasumasa Miyamoto, Tomoyuki Matsuda, Masaki Tanaka.   

Abstract

Relaxin-3 (RLN3) is a neuropeptide belonging to the insulin-relaxin superfamily. RLN3-expressing neurons are predominantly located in the dorsal pons known as the nucleus incertus, and project their axons to the forebrain including the hypothalamus. RLN3 has been suggested to be involved in the stress response. In the present study, we investigated the hypothalamic action of RLN3 in the stress-response system by intracerebroventricular (icv) administration of RLN3. Compared with saline icv injection, 1 nmol icv RLN3 injection induced c-Fos expression in the paraventricular nucleus of the hypothalamus (PVN) at 1 h after administration. Some RLN3-induced c-Fos-positive cells in the PVN were also corticotropin-releasing factor (CRF)-expressing neurons. CRF and c-fos mRNA levels in the PVN were increased at 2 h after RLN3 administration. Plasma adrenocorticotropic hormone (ACTH) levels were also increased after RLN3 administration. These results suggest that RLN3 is able to stimulate the hypothalamopituitary CRF-ACTH system during the acute response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21072619     DOI: 10.1007/s12031-010-9468-0

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  26 in total

1.  The novel G-protein coupled receptor SALPR shares sequence similarity with somatostatin and angiotensin receptors.

Authors:  M Matsumoto; M Kamohara; T Sugimoto; K Hidaka; J Takasaki; T Saito; M Okada; T Yamaguchi; K Furuichi
Journal:  Gene       Date:  2000-05-02       Impact factor: 3.688

2.  Restricted, but abundant, expression of the novel rat gene-3 (R3) relaxin in the dorsal tegmental region of brain.

Authors:  Tanya C D Burazin; Ross A D Bathgate; Mary Macris; Sharon Layfield; Andrew L Gundlach; Geoffrey W Tregear
Journal:  J Neurochem       Date:  2002-09       Impact factor: 5.372

3.  Chronic intracerebroventricular administration of relaxin-3 increases body weight in rats.

Authors:  Takayuki Hida; Eiki Takahashi; Kodo Shikata; Tomoko Hirohashi; Toru Sawai; Takashi Seiki; Hirokazu Tanaka; Takatoshi Kawai; Osamu Ito; Toru Arai; Akira Yokoi; Tetsuya Hirakawa; Hiroo Ogura; Takeshi Nagasu; Norimasa Miyamoto; Junro Kuromitsu
Journal:  J Recept Signal Transduct Res       Date:  2006       Impact factor: 2.092

4.  Hypothalamo-pituitary-adrenal axis sensitization after chronic salt loading.

Authors:  F Amaya; M Tanaka; S Hayashi; Y Tanaka; Y Ibata
Journal:  Neuroendocrinology       Date:  2001-03       Impact factor: 4.914

5.  Human relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene. Novel members of the relaxin peptide family.

Authors:  Ross A D Bathgate; Chrishan S Samuel; Tanya C D Burazin; Sharon Layfield; Antonia A Claasz; Irna Grace T Reytomas; Nicola F Dawson; Chongxin Zhao; Courtney Bond; Roger J Summers; Laura J Parry; John D Wade; Geoffrey W Tregear
Journal:  J Biol Chem       Date:  2001-10-31       Impact factor: 5.157

Review 6.  Receptors for relaxin family peptides.

Authors:  Ross A Bathgate; Richard Ivell; Barbara M Sanborn; O David Sherwood; Roger J Summers
Journal:  Ann N Y Acad Sci       Date:  2005-05       Impact factor: 5.691

7.  Central relaxin-3 administration causes hyperphagia in male Wistar rats.

Authors:  B M C McGowan; S A Stanley; K L Smith; N E White; M M Connolly; E L Thompson; J V Gardiner; K G Murphy; M A Ghatei; S R Bloom
Journal:  Endocrinology       Date:  2005-04-21       Impact factor: 4.736

8.  Distribution of G-protein-coupled receptor (GPCR)135 binding sites and receptor mRNA in the rat brain suggests a role for relaxin-3 in neuroendocrine and sensory processing.

Authors:  Steven W Sutton; Pascal Bonaventure; Chester Kuei; Barbara Roland; Jingcai Chen; Diane Nepomuceno; Timothy W Lovenberg; Changlu Liu
Journal:  Neuroendocrinology       Date:  2005-01-26       Impact factor: 4.914

9.  Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7.

Authors:  Changlu Liu; Jingcai Chen; Chester Kuei; Steven Sutton; Diane Nepomuceno; Pascal Bonaventure; Timothy W Lovenberg
Journal:  Mol Pharmacol       Date:  2004-10-01       Impact factor: 4.436

10.  Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135.

Authors:  Changlu Liu; Elo Eriste; Steven Sutton; Jingcai Chen; Barbara Roland; Chester Kuei; Niven Farmer; Hans Jörnvall; Rannar Sillard; Timothy W Lovenberg
Journal:  J Biol Chem       Date:  2003-09-30       Impact factor: 5.157

View more
  20 in total

1.  Relaxin-3/RXFP3 signalling in mouse hypothalamus: no effect of RXFP3 activation on corticosterone, despite reduced presynaptic excitatory input onto paraventricular CRH neurons in vitro.

Authors:  C Zhang; D V Baimoukhametova; C M Smith; J S Bains; Andrew L Gundlach
Journal:  Psychopharmacology (Berl)       Date:  2017-03-17       Impact factor: 4.530

Review 2.  Sex-specific effects of relaxin-3 on food intake and body weight gain.

Authors:  Juliane Calvez; Camila de Ávila; Elena Timofeeva
Journal:  Br J Pharmacol       Date:  2016-07-13       Impact factor: 8.739

Review 3.  Insulin/IGF signaling in Drosophila and other insects: factors that regulate production, release and post-release action of the insulin-like peptides.

Authors:  Dick R Nässel; Jozef Vanden Broeck
Journal:  Cell Mol Life Sci       Date:  2015-10-15       Impact factor: 9.261

4.  Inhibition of oxytocin and vasopressin neuron activity in rat hypothalamic paraventricular nucleus by relaxin-3-RXFP3 signalling.

Authors:  Alan Kania; Anna Gugula; Agnieszka Grabowiecka; Camila de Ávila; Tomasz Blasiak; Zenon Rajfur; Marian H Lewandowski; Grzegorz Hess; Elena Timofeeva; Andrew L Gundlach; Anna Blasiak
Journal:  J Physiol       Date:  2017-02-27       Impact factor: 5.182

5.  Relaxin peptide hormones are protective during the early stages of ischemic stroke in male rats.

Authors:  Lindsay H Bergeron; Jordan M Willcox; Faisal J Alibhai; Barry J Connell; Tarek M Saleh; Brian C Wilson; Alastair J S Summerlee
Journal:  Endocrinology       Date:  2014-12-02       Impact factor: 4.736

Review 6.  Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain.

Authors:  Sherie Ma; Craig M Smith; Anna Blasiak; Andrew L Gundlach
Journal:  Br J Pharmacol       Date:  2016-12-04       Impact factor: 8.739

7.  Sensitivity to Chronic Methamphetamine Administration and Withdrawal in Mice with Relaxin-3/RXFP3 Deficiency.

Authors:  Mouna Haidar; Monica Lam; Berenice E Chua; Craig M Smith; Andrew L Gundlach
Journal:  Neurochem Res       Date:  2015-05-29       Impact factor: 3.996

8.  Relaxin-3/RXFP3 system regulates alcohol-seeking.

Authors:  Philip J Ryan; Hanna E Kastman; Elena V Krstew; K Johan Rosengren; Mohammed Akhter Hossain; Leonid Churilov; John D Wade; Andrew L Gundlach; Andrew J Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

9.  Effects of chronic silencing of relaxin-3 production in nucleus incertus neurons on food intake, body weight, anxiety-like behaviour and limbic brain activity in female rats.

Authors:  Camila de Ávila; Sandrine Chometton; Sherie Ma; Lola Torz Pedersen; Elena Timofeeva; Carlo Cifani; Andrew L Gundlach
Journal:  Psychopharmacology (Berl)       Date:  2020-01-03       Impact factor: 4.530

10.  New insights into ligand-receptor pairing and coevolution of relaxin family peptides and their receptors in teleosts.

Authors:  Sara Good; Sergey Yegorov; Joran Martijn; Jens Franck; Jan Bogerd
Journal:  Int J Evol Biol       Date:  2012-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.